Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Keating

Showing results (711-720 of 963) with videos related to

Pageof 97
Sort By:
Blood|May 1, 1992
Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSFE Estey, P F Thall, H Kantarjian, et al.
Leukemia & Lymphoma|January 28, 1999
Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S M O'Brien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Multiple Amb a I allergens demonstrate specific reactivity with IgE and T cells from ragweed-allergic patientsJ F Bond, R D Garman, K M Keating, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1986
Clinical pharmacology of polyethylene glycol-L-asparaginaseD H Ho, N S Brown, A Yen, et al.
Journal of Integrative Bioinformatics|November 4, 2015
The Systems Biology Markup Language (SBML) Level 3 Package: Qualitative Models, Version 1, Release 1Claudine Chaouiya, Sarah M Keating, Duncan Berenguier, et al.
American Journal of Clinical Oncology|August 1, 1986
High-dose cyclophosphamide, BCNU, and etoposide followed by autologous bone marrow rescue as treatment for adult acute leukemia in relapseL Vellekoop, S Jagannath, G Spitzer, et al.
Blood|November 26, 1999
Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemiaA Aguayo, E Estey, H Kantarjian, et al.
Leukemia & Lymphoma|March 1, 1996
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dlA Sarris, J Cortes, H Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I studyM Beran, S Jeha, S O'Brien, et al.
Cancer Research|January 19, 1999
ATM mutations in B-cell chronic lymphocytic leukemiaF Bullrich, D Rasio, S Kitada, et al.
Pageof 97

Showing results (711-720 of 963) with videos related to

Sort By:
Pageof 97
Blood|May 1, 1992
Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSFE Estey, P F Thall, H Kantarjian, et al.
Leukemia & Lymphoma|January 28, 1999
Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemiaM Beran, E Estey, S M O'Brien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Multiple Amb a I allergens demonstrate specific reactivity with IgE and T cells from ragweed-allergic patientsJ F Bond, R D Garman, K M Keating, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1986
Clinical pharmacology of polyethylene glycol-L-asparaginaseD H Ho, N S Brown, A Yen, et al.
Journal of Integrative Bioinformatics|November 4, 2015
The Systems Biology Markup Language (SBML) Level 3 Package: Qualitative Models, Version 1, Release 1Claudine Chaouiya, Sarah M Keating, Duncan Berenguier, et al.
American Journal of Clinical Oncology|August 1, 1986
High-dose cyclophosphamide, BCNU, and etoposide followed by autologous bone marrow rescue as treatment for adult acute leukemia in relapseL Vellekoop, S Jagannath, G Spitzer, et al.
Blood|November 26, 1999
Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemiaA Aguayo, E Estey, H Kantarjian, et al.
Leukemia & Lymphoma|March 1, 1996
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dlA Sarris, J Cortes, H Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I studyM Beran, S Jeha, S O'Brien, et al.
Cancer Research|January 19, 1999
ATM mutations in B-cell chronic lymphocytic leukemiaF Bullrich, D Rasio, S Kitada, et al.
Pageof 97